Valentin Voillet

Fred Hutch Cancer Center — United States

Medicine · Health Sciences

19h-index3.2kcitations128works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(66), Immunotherapy and Immune Responses(21), Immune Cell Function and Interaction(19), Cancer Research and Treatments(17), T-cell and B-cell Immunology(13)

Publications127 total

A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands
Nature Communications·2026Open Access
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial
EBioMedicine·2025Open Access
Triple checkpoint blockade, but not anti-PD-1 alone, enhances engineered adoptive T cell therapy in a mouse model of advanced ovarian cancer 2090
The Journal of Immunology·2025Open Access
Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer
Proceedings of the National Academy of Sciences·2025· 1 citedOpen Access
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence
Nature Communications·2025· 4 citedOpen Access
A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands
2025Open Access
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence
2024Open Access
Blasts Monocytic Myeloid-Derived Suppressor Cell Skewing Is a Potential Mechanism of AML Immune-Escape
Blood·2024Open Access
NK-like Skewing As the Key Driver of T Cell Dysfunction in AML: Implications for Enhancing TCR-T Cell Therapy Efficacy
Blood·2024
Dysfunctional bronchoalveolar effector memory CD8+ T cells in tuberculosis-exposed people living with antiretroviral-naïve HIV infection
iScience·2024Open Access
Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection Model
ImmunoHorizons·2024· 1 citedOpen Access
Table S3 from Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor–Adoptive T-cell Therapy
2024Open Access
Table S1 from Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor–Adoptive T-cell Therapy
2024Open Access
Table S1 from Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor–Adoptive T-cell Therapy
2024Open Access
Data from Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor–Adoptive T-cell Therapy
2024Open Access
Table S3 from Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor–Adoptive T-cell Therapy
2024Open Access
Table S2 from Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor–Adoptive T-cell Therapy
2024Open Access
Data from Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor–Adoptive T-cell Therapy
2024Open Access
Table S4 from Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor–Adoptive T-cell Therapy
2024Open Access
Table S2 from Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor–Adoptive T-cell Therapy
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Raphaël Gottardo(35), Philip D. Greenberg(14), Laurence Liaubet(9), Stanley R. Riddell(8), Kristin G. Anderson(8), Breanna M. Bates(8), Aude G. Chapuis(7), Cecilia C.S. Yeung(7), Martin Prlic(7), Madison G. Burnett(7), Yapeng Su(6), David G. Maloney(6), Kelly G. Paulson(6), M. Juliana McElrath(6), Yvon Billon(6), Kimberly S. Smythe(5), Robert H. Pierce(5), Daniel Hunter(5), Paul Nghiem(5), Florian Mair(5)